The global vascular access devices market, valued at US$5.60 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, ...
Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Neonav electrocardiogram (ECG) tip location system, a central venous access device (CVAD) placement platform developed by ...
The first-of-its-kind collaboration will pool the entities’ resources to advance the monitoring of pressure conditions.
The risk for cancer increases after cerebral venous thrombosis, especially in men older than 50 years; a new study calls for ...